This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Jiangsu Province Hospital of Chinese Medicine, Nanjing Legend Biotech., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations and Contributions of Inventor Yue Han
Introduction
Yue Han is a notable inventor based in Nanjing, China. He has made significant contributions to the field of medicine, particularly in the development of treatments for cervical cancer. With a total of 2 patents, his work reflects a commitment to advancing healthcare solutions.
Latest Patents
One of Yue Han's latest patents focuses on the use of atractylenolide I in the preparation of medicine for preventing and/or treating cervical cancer. This patent describes a compound represented by formula I, or its various forms, which can be utilized in medical preparations aimed at combating cervical cancer. The invention emphasizes the combination of atractylenolide I with a P2X7R antagonist to achieve a synergistic effect in inhibiting the proliferation of SiHa cells. Another significant patent involves CD19 binding molecules and their various uses, showcasing his innovative approach to medical research.
Career Highlights
Yue Han has worked with prominent organizations such as Nanjing Legend Biotech, Ltd. and Jiangsu Province Hospital of Chinese Medicine. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Yue has collaborated with notable colleagues, including Xiaohu Fan and Zhe Zhou. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yue Han's innovative work in the field of medicine, particularly in cancer treatment, highlights his role as a significant inventor. His patents and collaborations reflect a dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile